Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block
Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block: a Prospective, Randomized, Double-blind, Traditional Controlled Study
Tongji Hospital
252 participants
Jan 1, 2022
INTERVENTIONAL
Conditions
Summary
1. Efficacy of a modified auriculotemporal nerve blockade for patients undergoing supratentorial craniotomy 2. Safety of a modified auriculotemporal nerve blockade for patients undergoing supratentorial craniotomy
Eligibility
Inclusion Criteria3
- Patients undergoing supratentorial craniotomy under general anesthesia;
- years old;
- ASA I or II.
Exclusion Criteria12
- Emergency surgery;
- Be allergic to ropivacaine;
- Participating in other clinical investigation within 30 days;
- Skin infection at the puncture site;
- Patients taking analgesic drugs before surgery;
- Persons addicted to alcohol or drugs;
- Patients with severe liver and kidney dysfunction;
- Patients with coagulation disorder;
- Pregnant and lactating women;
- Patients with consciousness disorder before surgery;
- Those who have undergone neurosurgery within the last 6 months;
- Patients who were unable to understand the NRS before surgery.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Helix feet in front of the zygomatic arch is served as anatomy marks of auriculotemporal nerve block, and the modified auriculotemporal nerve blockade is implemented as follows: Zygomatic arch level, posterior to the superficial temporal artery, the vertical puncture depth is about 0.5 -1 cm, and 2 ml of local anesthetics are injected after withdrawing without blood.
Traditional auriculotemporal nerve blockade
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05556889